SCHEMBL31228151

SCHEMBL31228151

OC[C@@]1(F)O[C@@H](n2ccc3c(C4CC4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 3/20 0.40
▸ ADK P55263 3/20 0.39
▸ WDR77 Q9BQA1 2/20 0.38
▸ METTL3 Q86U44 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228076 0.84 ADK (0.41) PRMT5ADKWDR77
SCHEMBL31228185 0.83 PRMT5 (0.51) PRMT5WDR77
SCHEMBL31228198 0.83 ADK (0.57) PRMT5ADKWDR77METTL3
SCHEMBL31228235 0.83 PRMT5 (0.44) PRMT5ADKWDR77METTL3
SCHEMBL31228144 0.83 PRMT5 (0.44) PRMT5ADKWDR77METTL3
SCHEMBL31228232 0.80 SLC29A1 (0.44) PRMT5WDR77
SCHEMBL31228186 0.80 PRMT5 (0.46) PRMT5ADKWDR77
SCHEMBL31228562 0.75 PRMT5 (0.44) PRMT5ADKWDR77
SCHEMBL31228288 0.75 ADORA3 (0.37) PRMT5ADKWDR77
SCHEMBL31228126 0.70 PRMT5 (0.41) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback